Add to ORKGdynamics of prostate cancer patients treated with intermittent androgen suppressio
Background: In metastatic prostate cancer (PCa) patients, androgen-deprivation therapy (ADT) combine...
OBJECTIVES: To analyze the predictive value of PSA for progression and the role of testosterone for ...
AbstractConsiderable research is aimed at determining the mechanisms by which hormone-refractory pro...
Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermit...
Predicting the timing of a castrate resistant prostate cancer is critical to lowering medical costs ...
The purpose of this research is to carry out a quantitative study of prostate-specific antigen dynam...
Intermittent androgen deprivation therapy is often used to treat prostate cancer, but there are few ...
This retrospective study shows that the majority of patients’ correlations between PSA and Testoster...
A mathematical model for the treatment of prostate cancer regarding androgen ablation is considered....
<div><p>When a physician decides on a treatment and its schedule for a specific patient, information...
Prostate Specific Antigen (PSA) is a biochemical marker used to monitor prostate cancer following tr...
Previous studies on prostate cancer modeling under hormonal therapy successfully fit clinical serum ...
The online version of this article, along with updated information and services, is located o
The prostate specific antigen(PSA) has the most available clinical value in monitoring the disease s...
Hormone naïve advanced prostate cancer is subdivided into two disease states: biochemical recurrence...
Background: In metastatic prostate cancer (PCa) patients, androgen-deprivation therapy (ADT) combine...
OBJECTIVES: To analyze the predictive value of PSA for progression and the role of testosterone for ...
AbstractConsiderable research is aimed at determining the mechanisms by which hormone-refractory pro...
Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermit...
Predicting the timing of a castrate resistant prostate cancer is critical to lowering medical costs ...
The purpose of this research is to carry out a quantitative study of prostate-specific antigen dynam...
Intermittent androgen deprivation therapy is often used to treat prostate cancer, but there are few ...
This retrospective study shows that the majority of patients’ correlations between PSA and Testoster...
A mathematical model for the treatment of prostate cancer regarding androgen ablation is considered....
<div><p>When a physician decides on a treatment and its schedule for a specific patient, information...
Prostate Specific Antigen (PSA) is a biochemical marker used to monitor prostate cancer following tr...
Previous studies on prostate cancer modeling under hormonal therapy successfully fit clinical serum ...
The online version of this article, along with updated information and services, is located o
The prostate specific antigen(PSA) has the most available clinical value in monitoring the disease s...
Hormone naïve advanced prostate cancer is subdivided into two disease states: biochemical recurrence...
Background: In metastatic prostate cancer (PCa) patients, androgen-deprivation therapy (ADT) combine...
OBJECTIVES: To analyze the predictive value of PSA for progression and the role of testosterone for ...
AbstractConsiderable research is aimed at determining the mechanisms by which hormone-refractory pro...